Periprosthetic Joint Infection Clinical Trial
Official title:
A Prospective, Multi-Center Study to Evaluate the Safety and Effectiveness of the REMEDY SPECTRUM IM Spacer Nail in the Treatment of Ankle-Related Infections
Verified date | May 2024 |
Source | OsteoRemedies, LLC |
Contact | Grace Montes |
Phone | 5712292683 |
gmontes[@]mcra.com | |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study is being conducted to evaluate the safety and effectiveness of the REMEDY SPECTRUM IM Spacer Nail in the treatment of ankle-related infections. The study is expected to take approximately 18 months from first subject enrolled to the last follow-up visit. It will have a 12-month enrollment period and a 6-month follow-up. This study is a Prospective, multicenter, single-arm clinical trial. All subjects enrolled in this study will receive the REMEDY SPECTRUM IM Spacer Nail.
Status | Not yet recruiting |
Enrollment | 60 |
Est. completion date | August 2026 |
Est. primary completion date | February 2026 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 21 Years and older |
Eligibility | Inclusion Criteria: 1. Be = 21 years of age 2. Have an ankle-related infection 3. Is skeletally mature, as evidenced by closed epiphyses. 4. Be able to give voluntary, written informed consent to participate and have signed an Informed Consent Form specific to this study 5. Be willing and able to comply with all study procedures including all pre-operative, post-operative requirements 6. If female and of child-bearing potential, must have a negative pregnancy test prior to the surgical procedure and no intention of becoming pregnant until study completion. Exclusion Criteria: 1. Infections that do not involve the ankle 2. Have a known immunodeficiency; including subjects who are receiving or have received immunosuppressants, immunostimulating agents or radiation therapy within 6 months prior to surgery 3. Affected limb is dysvascular 4. Where adequate soft-tissue coverage cannot be achieved 5. Have any mental or psychological disorder that would impair their ability to complete the study questionnaires 6. Are currently pregnant or breastfeeding, or planning to become pregnant or breastfeed any time during the course of the study 7. Are currently a prisoner 8. Have any medical condition or other circumstances, in the judgment of the Investigator, that might interfere with the ability to return for follow-up visits, including any systemic illness, neuromuscular, neurosensory, or musculoskeletal deficiency that would render the subject unable to perform appropriate post-operative activities. 9. History of vancomycin or gentamicin allergy 10. Are implanted with other antibiotic eluting products. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
OsteoRemedies, LLC | MCRA |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Successful Treatment of Infection Based on Lab Values and Culture | Healed wound and no infection recurrence caused by the same organism strain infection for duration of two weeks post antibiotic regimen. | 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT02530229 -
Arthrocentesis Study
|
N/A | |
Recruiting |
NCT06126614 -
Infection Prophylaxis in Total Joint Replacement
|
Phase 3 | |
Enrolling by invitation |
NCT05640336 -
Treatment of Acute Periprosthetic Joint Infection Comparing Single and Planned Double-Debridement Antibiotics and Implant Retention Followed by Chronic Antibiotic Suppression
|
N/A | |
Completed |
NCT03139539 -
Intraoperative Microbial Contamination
|
N/A | |
Recruiting |
NCT06268795 -
A Diagnostic Test Accuracy Study Comparing Biopsy to Aspiration in Shoulder and Elbow Arthroplasty Revision Surgery (BASE Study)
|
||
Recruiting |
NCT05357287 -
Closed Incisional Negative Pressure Wound Therapy in Post-surgical Wound Care of Patients With Periprosthetic Joint Infection
|
N/A | |
Active, not recruiting |
NCT05084378 -
Evaluation of Emerging New Treatments for Infection Prevention in Total Joint Replacement
|
Phase 3 | |
Recruiting |
NCT02868736 -
Clinical Validation of CD Diagnostics Synovasure PJI ELISA Test and Synovasure PJI Lateral Flow Test for Detection of Periprosthetic Joint Infection in Synovial Fluid
|
N/A | |
Not yet recruiting |
NCT06464770 -
Optimizing Infection Prophylaxis Prior to Shoulder Surgery
|
N/A | |
Terminated |
NCT04274517 -
Microbial Growth in Operative Splash Basins During Total Joint Arthroplasty
|
N/A | |
Recruiting |
NCT05284318 -
Prospective Cohort Study on Antibiotic Course and Efficacy After Two-stage Revision in PJI.
|
||
Not yet recruiting |
NCT06189885 -
Preoperative Daptomycin Prophylaxis in Two-Stage Exchange Arthroplasty: A Prospective, Randomized, Double-Blinded Trial
|
N/A | |
Enrolling by invitation |
NCT05320354 -
Diagnosis and Bacterial Identification of Periprosthetic Joint Infection With Microbial-ID
|
||
Recruiting |
NCT05495815 -
Proper Duration of Suppressive Antibiotic Therapy After Debridement, Antibiotics, and Implant Retention
|
N/A |